Safety Rates Drug Report: LAMIVUDINE. Immune reconstitution inflammatory syndrome adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: LAMIVUDINE. Injury: Immune reconstitution inflammatory syndrome Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
96989152	LAMIVUDINE.	Immune reconstitution inflammatory syndrome	BRISTOL MYERS SQUIBB	57.00 YR	M	0	20160720	US
102364603	LAMIVUDINE.	Immune reconstitution inflammatory syndrome	BRISTOL MYERS SQUIBB	36.00 YR	M	0	20160714	US
125977121	LAMIVUDINE.	Immune reconstitution inflammatory syndrome	MYLAN	0.00		0	20160726	ZA
125984821	LAMIVUDINE.	Immune reconstitution inflammatory syndrome	MYLAN	0.00		0	20160727	ZA
125999351	LAMIVUDINE.	Immune reconstitution inflammatory syndrome	MYLAN	0.00		0	20160727	ZA
126755271	LAMIVUDINE.	Immune reconstitution inflammatory syndrome	STRIDES	0.00		0	20160823	ZA
126760601	LAMIVUDINE.	Immune reconstitution inflammatory syndrome	AUROBINDO	42.00 YR	F	0	20160823	ZA
126760661	LAMIVUDINE.	Immune reconstitution inflammatory syndrome	AUROBINDO	31.00 YR	F	0	20160823	ZA
126760911	LAMIVUDINE.	Immune reconstitution inflammatory syndrome	AUROBINDO	35.00 YR	F	0	20160823	ZA

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Execution Time: 0.013456106185913 seconds (ucode:5255215). Developed by: James D. Barger